Target intelligence / Profile preview

General control non-repressed protein 5 (GCN5)

Target
GCN5
Molecular classification
Histone acetyltransferase (HAT), Lysine acetyltransferase (KAT), Chromatin modifier, Transcription co-activator
01

Overview

General control non-repressed protein 5 (GCN5), also known as lysine acetyltransferase 2A (KAT2A), is a highly conserved histone acetyltransferase (HAT) that plays a central role in epigenetic regulation of gene expression by acetylating histone and non-histone proteins. This activity facilitates transcriptional activation by remodeling chromatin structure to allow gene transcription. GCN5 regulates diverse biological processes, including metabolism, cellular proliferation, and the response to environmental and developmental signals. Dysfunction of GCN5 has been implicated in a range of disorders, notably cancer, metabolic, and neurological diseases. In plant biology, GCN5 has been shown to regulate iron homeostasis and fatty acid biosynthesis. Although it represents an appealing therapeutic target, direct clinical inhibitors are lacking, and therapeutic approaches must contend with the protein’s broad and essential cellular functions.

Other names
General control non-depressible 5Lysine acetyltransferase 2A (KAT2A)GCN5 acetyltransferase
02

Mechanism of action

Inhibition of GCN5 decreases histone acetylation leading to transcriptional repression of its target genes. Modulation of GCN5 may alter acetylation status of metabolic and cell cycle regulators impacting cellular metabolism, stress response, and potentially tumor growth.

03

Biological functions

Epigenetic regulation of gene expressionTranscriptional activation via histone acetylationRegulation of metabolismRegulation of cell proliferation, proliferation, and differentiationResponse to environmental and developmental stimuliAcetylation of non-histone proteins including p53, c-Myc, PGC-1αRegulation of fatty acid biosynthesis (in plants)Regulation of iron homeostasis (in plants)
04

Disease associations

CancerMetabolic disorders (e.g., diabetes, obesity)Neurological disordersAutoimmune disordersOther: roles in inflammation and possibly plant nutritional quality
05

Safety considerations

Broad impact on gene expression: risk of widespread transcriptional dysregulation if targeted therapeuticallyPotential for off-target effects due to redundancy with other acetyltransferases (e.g., PCAF)May affect multiple essential cellular pathways, requiring careful targeting
06

Interacting drugs

No well-established, approved drugs directly target GCN5 in the clinic as of 2025. Experimental small molecule inhibitors and modulators of histone acetyltransferase activity exist, but clinical relevance remains limited.
07

Biomarkers

H3K9ac and H3K14ac acetylation levels can serve as indirect biomarkers of GCN5 activityGCN5 expression levels (mRNA/protein) can be explored as a biomarker in specific pathologies, such as certain cancers or metabolic diseases

Beyond the preview

Go deeper on General control non-repressed protein 5 (GCN5).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on General control non-repressed protein 5 (GCN5).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call